Unknown

Dataset Information

0

In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP? receptor antagonist.


ABSTRACT: BACKGROUND AND PURPOSE:Studies of the role of the prostaglandin EP(2) receptor) have been limited by the availability of potent and selective antagonist tools. Here we describe the in vitro/in vivo pharmacological characterization of a novel EP(2) receptor antagonist, PF-04418948 (1-(4-fluorobenzoyl)-3-{[(6-methoxy-2-naphthyl)oxy]methyl} azetidine-3-carboxylic acid). EXPERIMENTAL APPROACH:Functional antagonist potency was assessed in cell-based systems expressing human EP(2) receptors and native tissue preparations from human, dog and mouse. The selectivity of PF-04418948 was assessed against related receptors and a panel of GPCRs, ion channels and enzymes. The ability of PF-04418948 to pharmacologically block EP(2) receptor function in vivo was tested in rats. KEY RESULTS:PF-04418948 inhibited prostaglandin E(2)(PGE(2))-induced increase in cAMP in cells expressing EP(2) receptors with a functional K(B) value of 1.8 nM. In human myometrium, PF-04418948 produced a parallel, rightward shift of the butaprost-induced inhibition of the contractions induced by electrical field stimulation with an apparent K(B) of 5.4 nM. In dog bronchiole and mouse trachea, PF-04418948 produced parallel rightward shifts of the PGE(2)-induced relaxation curve with a K(B) of 2.5 nM and an apparent K(B) of 1.3 nM respectively. Reversal of the PGE(2)-induced relaxation in the mouse trachea by PF-04418948 produced an IC(50) value of 2.7 nM. Given orally, PF-04418948 attenuated the butaprost-induced cutaneous blood flow response in rats. PF-04418948 was selective for EP(2) receptors over homologous and unrelated receptors, enzymes and channels. CONCLUSIONS AND IMPLICATIONS:PF-04418948 is an orally active, potent and selective surmountable EP(2) receptor antagonist that should aid further elaboration of EP(2) receptor function.

SUBMITTER: af Forselles KJ 

PROVIDER: S-EPMC3246710 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist.

af Forselles K J KJ   Root J J   Clarke T T   Davey D D   Aughton K K   Dack K K   Pullen N N  

British journal of pharmacology 20111201 7


<h4>Background and purpose</h4>Studies of the role of the prostaglandin EP(2) receptor) have been limited by the availability of potent and selective antagonist tools. Here we describe the in vitro/in vivo pharmacological characterization of a novel EP(2) receptor antagonist, PF-04418948 (1-(4-fluorobenzoyl)-3-{[(6-methoxy-2-naphthyl)oxy]methyl} azetidine-3-carboxylic acid).<h4>Experimental approach</h4>Functional antagonist potency was assessed in cell-based systems expressing human EP(2) recep  ...[more]

Similar Datasets

| S-EPMC3963132 | biostudies-literature
| S-EPMC4018168 | biostudies-literature
| S-EPMC4160761 | biostudies-literature
| S-EPMC2697788 | biostudies-literature
| S-EPMC3728309 | biostudies-literature
| S-EPMC7722660 | biostudies-literature
| S-EPMC9229160 | biostudies-literature
| S-EPMC5759725 | biostudies-literature
| S-EPMC4027753 | biostudies-literature
| S-EPMC5334202 | biostudies-literature